#authorizes #Lilly #market #KwikPen #prefilled #tirzepatide The European Commission (EC) has granted Eli Lilly and Company an authorization to market the KwikPen injection device for the administration of tirzepatide (Mounjaro) in its two indications: In adults with insufficiently controlled type 2 diabetes who cannot take metformin or in combination with other medications to treat diabetes, … Continue reading The EC authorizes Lilly to market its KwikPen pre-filled with tirzepatide